Department of Cardiology, Campus Virchow-Klinikum, Charité Universitätsmedizin Berlin, Berlin, Germany.
Eur J Heart Fail. 2010 Feb;12(2):122-8. doi: 10.1093/eurjhf/hfp184.
Acute heart failure syndromes, commonly recognized as de novo heart failure or acute decompensated chronic heart failure (ADHF), are characterized by a rapid onset or change in signs and symptoms of heart failure requiring urgent treatment. Coexisting renal dysfunction is associated with poor prognosis in these patients. We sought to determine whether renal impairment in particular and other admission factors in general predict long-term mortality after hospitalization for ADHF.
We studied 128 patients (age 63 + or - 12 years, 76% male) in NYHA class 2.6 + or - 0.7 with a left ventricular ejection fraction (LVEF) < or = 39%, hospitalized due to ADHF. Mortality rates (per 100 person-years) were 21.9 at 12 months and 12.0 at 60 months. We found that admission serum creatinine level was the best predictor of mortality after 1 (P < 0.001, log-transformed due to skewed distribution) and 5 years (P = 0.001), followed by creatinine clearance, the use of loop diuretics, and digoxin. Moreover, higher NYHA class, decreased body mass index (BMI) and increased levels of urea predicted 1 and 5 years mortality on univariate analysis. In the multivariate analysis, creatinine, NYHA class, and LVEF emerged as independent predictors of mortality after 1 year, whereas BMI and the use of diuretics did not reach significance (joint chi(2) = 29.40, P < 0.001). After 5 years, creatinine and NYHA class independently predicted all-cause mortality (joint chi(2) = 22.71, P < 0.001), but BMI and age did not remain significant.
Admission creatinine level strongly predicts medium- and long-term mortality after hospitalization in patients with ADHF, and serves as a cheap and fast clinical marker to identify patients at risk of death.
急性心力衰竭综合征,通常被认为是新发心力衰竭或急性失代偿性慢性心力衰竭(ADHF),其特征为心力衰竭的体征和症状迅速发作或改变,需要紧急治疗。这些患者并存的肾功能不全与预后不良相关。我们旨在确定肾功能不全特别是其他入院因素是否可预测 ADHF 住院后长期死亡率。
我们研究了 128 例(年龄 63±12 岁,76%为男性)NYHA 分级 2.6±0.7 级,左心室射血分数(LVEF)≤39%,因 ADHF 住院的患者。12 个月和 60 个月的死亡率(每 100 人年)分别为 21.9%和 12.0%。我们发现入院时血清肌酐水平是 1 年(P<0.001,由于偏态分布而进行对数转换)和 5 年(P=0.001)死亡率的最佳预测指标,其次是肌酐清除率、使用袢利尿剂和地高辛。此外,更高的 NYHA 分级、较低的体重指数(BMI)和较高的尿素水平在单变量分析中预测了 1 年和 5 年的死亡率。在多变量分析中,肌酐、NYHA 分级和 LVEF 是 1 年后死亡率的独立预测指标,而 BMI 和利尿剂的使用未达到显著水平(联合卡方=29.40,P<0.001)。5 年后,肌酐和 NYHA 分级独立预测全因死亡率(联合卡方=22.71,P<0.001),但 BMI 和年龄不再显著。
入院时的肌酐水平强烈预测 ADHF 患者住院后中、长期死亡率,是一种廉价、快速的临床标志物,可识别有死亡风险的患者。